Reports of Ivermectin approval 'fake news', says Sahpra

accreditation
0:00
play article
Subscribers can listen to this article
 A general view of the drug Ivermectin.
A general view of the drug Ivermectin.
Photo by Gallo Images/Ziyaad Douglas
  • Reports that Ivermectin has been approved for use as a medicine in SA are fake, Sahpra says.
  • A screenshot of a supposed news report has been circulating on social media.
  • The health department also confirmed the reports were false.

The Department of Health says a report that Ivermectin has been registered as a medicine in South Africa is "fake news".

The department responded to a screen shot of a SABC News social media post, with a breaking news tag, claiming the medication had been approved for use.

Acting health minister Mmamoloko Kubayi's spokesperson, Hlengiwe Nhlabathi-Mokota, said the reports were incorrect and that the medication had not been approved for use in Covid-19 patients and without doctors having undertaken a Section 21 process with the South African Health Products Regulatory Authority (Sahpra).

In terms of the Medicines and Related Substances Control Act, a Section 21 application is used to apply for the prescription of medicine not registered for human use in South Africa.

READ | Ivermectin settlement: 'Sanctity of human life' top of mind, says ACDP

Sahpra spokesperson Yuven Gounden confirmed the reports were false. 

Sahpra added, in a social media post, that the image appeared to be "an old screen shot" that was being circulated.

In February, Sahpra agreed to allow doctors, in cases deemed urgent, to start Ivermectin treatment as soon as a Section 21 application had been submitted without waiting for the application's outcome.

Sahpra was hesitant to allow the use of Ivermectin for the treatment of Covid-19, saying there was not enough clinical evidence to support this.


Do you want to know more about this topic? Sign up for one of News24's 33 newsletters to receive the information you want in your inbox. Special newsletters are available to subscribers.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
The ANC's leadership race is heating up. Who do you think will be elected party president at Nasrec in December?
Please select an option Oops! Something went wrong, please try again later.
Results
Nkosazana Dlamini-Zuma has got it in the bag
7% - 866 votes
I foresee a second term for Cyril Ramaphosa
83% - 9905 votes
Don’t discount a Zweli Mkhize win
10% - 1153 votes
Vote
Rand - Dollar
18.08
-0.4%
Rand - Pound
20.09
+0.0%
Rand - Euro
17.69
-0.4%
Rand - Aus dollar
11.56
-0.2%
Rand - Yen
0.12
-0.4%
Gold
1,701.18
-0.7%
Silver
20.26
-1.9%
Palladium
2,244.50
-0.8%
Platinum
922.50
-0.3%
Brent Crude
94.42
+1.1%
Top 40
59,280
-0.2%
All Share
65,676
-0.2%
Resource 10
63,294
+0.0%
Industrial 25
79,505
-0.7%
Financial 15
14,072
+0.5%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE